Interaction between specific fatty acids, GLP-1 and insulin secretion in humans

Diabetologia

Volumn 45, Issue 11, 2002, Pages 1533-1541

  Beysen, C ^a   Karpe, F ^a   Fielding, B ^a   Clark, A ^a   Levy, J ^a   Frayn, K ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

GLP 1; Insulin secretion; Monounsaturated fatty acids; Polyunsaturated fatty acids; Saturated fatty acids

Indexed keywords

C PEPTIDE; FATTY ACID DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEPARIN; INSULIN; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; PROINSULIN; SATURATED FATTY ACID; ANTICOAGULANT AGENT; FATTY ACID; GLUCAGON; PEPTIDE FRAGMENT; PROTEIN PRECURSOR; UNSATURATED FATTY ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CALCULATION; CONTROLLED STUDY; FAT INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; REFERENCE VALUE; SECRETION;

ADULT; ANTICOAGULANTS; DIETARY FATS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, NONESTERIFIED; FATTY ACIDS, UNSATURATED; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HEPARIN; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; REFERENCE VALUES;

EID: 0036434385     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0964-9     Document Type: Article

References (55)

1. Opie LH, Walfish PG (1963) Plasma free fatty acid concentrations in obesity. N Engl J Med 268: 757-760
2. Charles MA, Eschwege E, Thibult N et al. (1997) The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: Results of the Paris Prospective Study. Diabetologia 40: 1101-1106
3. Paolisso G, Howard BV (1998) Role of non-esterified fatty acids in the pathogenesis of type 2 diabetes mellitus. Diabet Med 15: 360-366
4. Boden G, Chen X, Ruiz J, White JV, Rossetti L (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93: 2438-2446
5. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA (1983) Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72: 1737-1747
6. Fulcher GR, Farrer M, Thow JC (1990) The glucose-fatty acid cycle in non-insulin dependent diabetes mellitus: The acute effects of inhibition of lipolysis overnight with acipimox. Diabetes Nutr Metab 3: 285-293
7. Fanelli C, Calderone S, Epifano L et al. (1993) Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and supression of glucose utilization in humans. J Clin Invest 92: 1617-1622
8. Svedberg J, Björntorp P, Smith U, Lonnroth P (1990) Free fatty acid inhibition of insulin binding, degradation and action in isolated rat hepatocytes. Diabetes 39: 570-574
9. Wiesenthal SR, Sandhu H, McCall RH et al. (1999) Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 48: 766-774
10. Warnotte C, Gilon P, Nenquin M, Henquin J-C (1994) Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse β-cells. Diabetes 43: 703-711
11. Crespin SR, Greenough WB, Steinberg D (1974) Stimulation of insulin secretion by long chain free fatty acids. A direct pancreatic effect. J Clin Invest 52: 1979-1984
12. Chalkley SM, Kraegen EW, Furler SM, Campbell LV, Chisholm DJ (1998) NEFA elevation during a hyperglycaemic clamp enhances insulin secretion. Diabet Med 15: 327-333
13. Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF (1999) Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 276: E1055-E1066
14. Boden G, Chen X, Rosner J, Barton M (1995) Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44: 1239-1242
15. Paolisso A, Gambardella A, Amato L et al. (1995) Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38: 1295-1299
16. Heimberg M, Dunn GD, Wilcox G (1974) The derivation of plasma-free fatty acids from dietary neutral fat in man. J Lab Clin Med 83: 393-402
17. Alstrup KK, Gregersen S, Jensen H, Thomsen JL, Hermansen K (1999) Differential effects of cis and trans fatty acids on insulin release from isolated mouse islets. Metabolism 48: 22-29
18. Warnotte C, Nenquin M, Henquin J-C (1999) Unbound rather than total concentration and saturation rather than unsaturation determine the potency of fatty acids on insulin secretion. Mol Cell Endocrinol 153: 147-153
19. Stein DT, Stevenson BE, Chester ME et al. (1997) The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100: 398-403
20. Beysen C, Belcher AK, Karpe F, Fielding BA, Herrera E, Frayn KN (2002) A novel experimental protocol to increase specific plasma non-esterified fatty acids in man. Am J Physiol Endocrinol Metab (in press)
21. McGuire EAH, Helderman JH, Tobin JD, Andres R, Berman M (1976) Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41: 565-573
22. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223
23. Burdge GC, Wright P, Jones AE, Wootton SA (2000) A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br J Nutr 84: 781-787
24. Fielding BA, Callow J, Owen M, Samra JS, Matthews DR, Frayn KN (1996) Postprandial lipemia: The origin of an early peak studied by specific dietary fatty acid intake during sequential meals. Am J Clin Nutr 63: 36-41
25. Eaton R, Allen R, Schade D, Erickson K, Standefer J (1980) Prehepatic insulin production in man: Kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab 51: 520-528
26. Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41: 368-377
27. Horgan GW (2001) Statistical analysis of nutritional studies. Br J Nutr 86: 141-144
28. Roden M, Stingl H, Chandramouli V et al. (2000) Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 49: 701-707
29. Amery CM, Round RA, Smith JM, Nattrass M (2000) Elevation of plasma fatty acids by ten-hour intralipid infusion has no effect on basal or glucose-stimulated insulin secretion in normal man. Metabolism 49: 450-454
30. Frias JP, Basabe L, Macaraeg G, Kruszynska YT (2000) Lack of effect of a physiological elevation of plasma non-esterified fatty acid levels on insulin secretion. Diabetes Metab 26: 133-139
31. Krebs M, Stingl H, Nowotny P et al. (2000) Prevention of in vitro lipolysis by tetrahydrolipstatin. Clin Chem 46: 950-954
32. Shah P, Vella A, Basu A et al. (2002) Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes 51: 301-310
33. Stefan N, Fritsche A, Häring H, Madaus A, Stumvoll M (2000) Stimulatory effect of increased non-esterified fatty acid concentrations on proinsulin processing in healthy humans. Diabetologia 43: 1368-1373
34. Heimberg M, Dunn GD, Wilcox G (1974) The derivation of plasma-free fatty acids from dietary neutral fat in man. J Lab Clin Med 83: 393-402
35. Fielding BA, Callow J, Owen M, Samra JS, Matthews DR, Frayn KN (1996) Postprandial lipemia: The origin of an early peak studied by specific dietary fatty acid intake during sequential meals. Am J Clin Nutr 63: 36-41
36. Jacobsen BK, Trygg K, Hjermann I, Thomassen MS, Real C, Norum KR (1983) Acyl patterns of adipose tissue triglycerides, plasma fatty acids, and diet of a group of men participating in a primary coronary prevention program (The Oslo Study). Am J Clin Nutr 38: 906-913
37. Leaf DA, Connor WE, Barstad L, Sexton G (1995) Incorporation of dietary n-3 fatty acids into the fatty acids of human adipose tissue and plasma lipid classes. Am J Clin Nutr 62: 68-73
38. Stefan N, Wahl HG, Fritsche A, Häring H, Stumvoll M (2001) Effect of pattern of elevated free fatty acids on insulin sensitivity and insulin secretion in healthy humans. Horm Metab Res 33: 432-438
39. Thomsen C, Rasmussen O, Lousen T et al. (1999) Differential effects of saturated and monounaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr 69: 1135-1143
40. Gatti E, Noe D, Pazzucconi F et al. (1992) Differential effects of unsaturated oils and butter on blood glucose and insulin response to carbohydrate in normals. Eur J Clin Nutr 46: 161-166
41. Vessby B, Unsitupa M, Hermansen K et al. (2001) Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study. Diabetologia 44: 312-319
42. Rasmussen OW, Lauszus FF, Christiansen C, Thomsen C, Hermansen K (1996) Differential effects of saturated and monounsaturated fat on blood glucose and insulin responses in subjects with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 63: 249-253
43. Dobbins RL, Bentley B, Myhill J, Tamura Y, Giacca A, McGarry JD (2001) The composition of dietary fat profoundly influences insulin secretion in rats. Diabetes 50: A320 (Abstract)
44. Lardinois CK, Starich GH, Mazzaferri EL, Delett A (1987) Polyunsaturated fatty acids augment insulin secretion. J Am Coll Nutr 6: 507-515
45. Pedersen A, Marckmann P, Sandström B (1999) Postprandial lipoprotein, glucose and insulin responses after two consecutive meals containing rapeseed oil, sunflower oil or palm oil with or without glucose at the first meal. Br J Nutr 82: 97-104
46. Picinato MC, Curi R, Machado UF, Carpinelli AR (1998) Soybean- and olive-oils-enriched diets increase insulin secretion to glucose stimulus in isolated pancreatic rat islets. Physiol Behav 65: 289-294
47. Kreymann B, Williams G, Ghatei MA, Bloom SR (1987) Glucagon-like peptide-1 7-36: A physiological incretin in man. Lancet ii: 1300-1304
48. Elliot RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V (1993) Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: Acute post-prandial and 24-h secretion patterns. J Endocrinol 138: 159-166
49. Brandt A, Katschinski M, Arnold R, Polonsky KS, Göke B, Byrne MM (2001) GLP-1 induced alterations in the glucose-stimulated insulin secretory dose-response curve. Am J Physiol 281: E242-E247
50. Holz GG, Kühtreiber WM, Habener JF (1993) Pancreatic beta-cells are rendered glucose-competent by the insulino-tropic hormone glucagon-like peptide-I (7-37). Nature 361: 362-365
51. Ockner RK, Pittman JP, Yager JL (1972) Differences in the intestinal absorption of saturated and unsaturated long-chain fatty acids. Gastroenterology 62: 981-992
52. Rocca AS, Brubaker PL (1995) Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in fetal rat intestinal cultures. Endocrinology 136: 5593-5599
53. Gallwitz B, Witt M, Morys-Wortmann C, Fölsch UR, Schmidt WE (1996) GLP-1/GIP chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1. Regul Pept 7: 17-22
54. Fehmann GC, Göke R, Göke B, Bächle R, Wagner B, Arnold R (1991) Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas. Biochim Biophys Acta 1091: 356-363
55. Ranganath L, Norris F, Morgan LM, Wright J, Marks V (1999) The effect of circulating non-esterified fatty acids on the entero-insular axis. Eur J Clin Invest 29: 27-32